NDC 16714-679 – Sunitinib malate
Sunitinib Malate 50 mg/1 · Capsule · Oral
Product NDC16714-679
Product details
- Brand name
- Sunitinib malate
- Generic name
- Sunitinib malate
- Labeler
- NorthStar RxLLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213914
- Marketed since
- February 18, 2022
- Marketing end
- September 30, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Sunitinib Malate 50 mg/1
Uses, dosage, side effects and warnings for Sunitinib Malate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 16714-679-01 | 28 CAPSULE in 1 BOTTLE (16714-679-01) | Feb 18, 2022 |
Other Sunitinib Malate products
- 59651-466 Sunitinib Malate 37.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-467 Sunitinib Malate 50 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-465 Sunitinib Malate 25 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-464 Sunitinib Malate 12.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 42291-904 Sunitinib Malate 50 mg/1 · Capsule · AvKARE
- 42291-903 Sunitinib Malate 37.5 mg/1 · Capsule · AvKARE
- 42291-901 Sunitinib Malate 12.5 mg/1 · Capsule · AvKARE
- 42291-902 Sunitinib Malate 25 mg/1 · Capsule · AvKARE
- 43598-045 Sunitinib Malate 12.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-046 Sunitinib Malate 25 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-047 Sunitinib Malate 37.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-048 Sunitinib Malate 50 mg/1 · Capsule · Dr.Reddys Laboratories Inc